載入...
Improvement of peripheral artery disease with Sildenafil and Bosentan combined therapy in a patient with limited cutaneous systemic sclerosis: A case report
RATIONALE: Sildenafil, a phosphodiesterase-5-inhibitor and Bosentan, an endothelin-1-receptor antagonist combined therapy could have beneficial effect in systemic sclerosis (SSc) patients with peripheral artery disease. PATIENT CONCERNS: We report a case of a 48-year-old Black woman, who developed s...
Na minha lista:
| 發表在: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Wolters Kluwer Health
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5484185/ https://ncbi.nlm.nih.gov/pubmed/28640077 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000006988 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|